Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
To view the full text, please login as a subscribed user or purchase a subscription. Click here to view the full text on ScienceDirect. The benefit of yttrium-90 (Y90) radioembolization in the setting of hepatic metastases from colorectal cancer is controversial in the salvage setting. This study assessed the efficacy of adding Y90 radioembolization to systemic therapy in patients with metastatic colorectal cancer to the liver.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
